UNLIMITED TURBO SHORT - DIASORIN Stock

P1XUZ8

NLBNPIT1XUZ8

Market Closed - Borsa Italiana 04:05:00 2024-05-31 pm EDT
21.79 ^EUR	+6.09%

1 month	-20.39%
3 months	-23.41%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Latest news about DIASORIN S.P.A.

Funds move on Banco BPM, DiaSorin and Webuild.	May. 30	AN
Futures bearish; focus on European data	May. 30	AN
Stock markets in the red; DiaSorin snap on Mib.	May. 29	AN
Indices flat; Newlat runs after Princes acquisition.	May. 27	AN

More news

Quotes 5-day view

Date	Price	Change
24-05-31	22.22	+8.18%
24-05-30	20.54	+0.20%
24-05-29	20.5	-9.41%
24-05-28	22.63	+0.85%
24-05-27	22.44	-2.43%

Real-time Borsa Italiana

Last update May 31, 2024 at 04:05 pm EDT

More quotes

Static data

Product type	Knock-Out ohne Stop Loss
Buy / Sell	PUT
Underlying	DIASORIN S.P.A.
Issuer	BNP Paribas
	P1XUZ8
ISIN	NLBNPIT1XUZ8
Date issued	2023-12-18
Strike	114.8 €
Maturity	Unlimited
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	39.37 €
Lowest since issue	18.75 €
Spread	1.5 €
Spread %	6.62%

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company

Ratings for DiaSorin S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: DiaSorin S.p.A.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

98.94 EUR

Average target price

100.1 EUR

Spread / Average Target

+1.15%

Consensus